Reply to "does progranulin account for the opposite effects of etanercept and infliximab/adalimumab in osteoarthritis?" by Wei et al.

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	15-16
Number of pages	2
Journal	Journal of Orthopaedic Research
Volume	34
Issue number	1
DOIs	https://doi.org/10.1002/jor.23095
State	Published - Jan 1 2016

Access to Document

@article{1c7f81ad78874e3287f710c41ba603c0,

title = "Reply to {"}does progranulin account for the opposite effects of etanercept and infliximab/adalimumab in osteoarthritis?{"} by Wei et al.",

author = "Olson, \{Steven A.\} and Furman, \{Bridgette D.\} and Kraus, \{Virginia B.\} and Huebner, \{Janet L.\} and Farshid Guilak",

year = "2016",

month = jan,

day = "1",

doi = "10.1002/jor.23095",

language = "English",

volume = "34",

pages = "15--16",

journal = "Journal of Orthopaedic Research",

issn = "0736-0266",

number = "1",

}

TY - JOUR

T1 - Reply to "does progranulin account for the opposite effects of etanercept and infliximab/adalimumab in osteoarthritis?" by Wei et al.

AU - Olson, Steven A.

AU - Furman, Bridgette D.

AU - Kraus, Virginia B.

AU - Huebner, Janet L.

AU - Guilak, Farshid

PY - 2016/1/1

Y1 - 2016/1/1

UR - https://www.scopus.com/pages/publications/84954078284

U2 - 10.1002/jor.23095

DO - 10.1002/jor.23095

M3 - Letter

C2 - 26519624

AN - SCOPUS:84954078284

SN - 0736-0266

VL - 34

SP - 15

EP - 16

JO - Journal of Orthopaedic Research

JF - Journal of Orthopaedic Research

IS - 1

ER -